IT8767057A0 - Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione - Google Patents

Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione

Info

Publication number
IT8767057A0
IT8767057A0 IT8767057A IT6705787A IT8767057A0 IT 8767057 A0 IT8767057 A0 IT 8767057A0 IT 8767057 A IT8767057 A IT 8767057A IT 6705787 A IT6705787 A IT 6705787A IT 8767057 A0 IT8767057 A0 IT 8767057A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
long
pharmaceutical compositions
dosage forms
Prior art date
Application number
IT8767057A
Other languages
English (en)
Other versions
IT1206876B (it
Inventor
Calum Brechin Macfarlane
Alastair Brereton Selkirk
Michael John Dey
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of IT8767057A0 publication Critical patent/IT8767057A0/it
Application granted granted Critical
Publication of IT1206876B publication Critical patent/IT1206876B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT8767057A 1986-01-30 1987-01-29 Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione IT1206876B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82389686A 1986-01-30 1986-01-30
US94087886A 1986-12-10 1986-12-10

Publications (2)

Publication Number Publication Date
IT8767057A0 true IT8767057A0 (it) 1987-01-29
IT1206876B IT1206876B (it) 1989-05-11

Family

ID=27124769

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8767057A IT1206876B (it) 1986-01-30 1987-01-29 Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione

Country Status (18)

Country Link
EP (1) EP0231026B1 (it)
JP (1) JP2524990B2 (it)
KR (1) KR900005009B1 (it)
AU (1) AU604672B2 (it)
CA (1) CA1285227C (it)
DE (1) DE3782439T2 (it)
DK (1) DK175216B1 (it)
ES (1) ES2052500T3 (it)
FI (1) FI88872C (it)
GR (1) GR3006148T3 (it)
HU (1) HU196709B (it)
IE (1) IE61879B1 (it)
IL (2) IL81419A0 (it)
IT (1) IT1206876B (it)
NO (1) NO174325C (it)
NZ (1) NZ219090A (it)
PH (1) PH26366A (it)
PT (1) PT84213B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IT1227336B (it) * 1987-09-11 1991-04-08 Squibb & Sons Inc Composizione farmaceutica contenente un carico elevato di medicamento e procedimento per la sua preparazione
JP2528706B2 (ja) * 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 ジヒドロピリジン化合物の製剤組成物
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
AU663146B2 (en) * 1991-12-30 1995-09-28 R.P. Scherer Technologies, Inc. Microcrystalline cellulose spheronization composition
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
GB2264639B (en) * 1992-02-20 1996-05-22 Euro Celtique Sa Modified Release Formulation
TW474824B (en) * 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
US6479496B1 (en) * 1998-09-10 2002-11-12 Cv Therapeutics, Inc. Methods for treating angina with ranolazine
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation

Also Published As

Publication number Publication date
IL81419A (en) 1991-07-18
HUT42950A (en) 1987-09-28
NO174325B (no) 1994-01-10
EP0231026B1 (en) 1992-11-04
DK175216B1 (da) 2004-07-12
PH26366A (en) 1992-06-01
KR870007121A (ko) 1987-08-17
JP2524990B2 (ja) 1996-08-14
IE61879B1 (en) 1994-11-30
PT84213B (pt) 1989-03-30
PT84213A (en) 1987-02-01
EP0231026A1 (en) 1987-08-05
HU196709B (en) 1989-01-30
DK47787D0 (da) 1987-01-29
GR3006148T3 (it) 1993-06-21
NO174325C (no) 1994-04-20
IL81419A0 (en) 1987-08-31
DE3782439D1 (de) 1992-12-10
JPS62252732A (ja) 1987-11-04
FI870380A (fi) 1987-07-31
DE3782439T2 (de) 1993-05-19
FI88872B (fi) 1993-04-15
NO870368L (no) 1987-07-31
DK47787A (da) 1987-07-31
IE870229L (en) 1987-07-30
CA1285227C (en) 1991-06-25
FI870380A0 (fi) 1987-01-29
AU6810287A (en) 1987-08-06
AU604672B2 (en) 1991-01-03
IT1206876B (it) 1989-05-11
KR900005009B1 (ko) 1990-07-16
ES2052500T3 (es) 1994-07-16
NZ219090A (en) 1990-04-26
FI88872C (fi) 1993-07-26
NO870368D0 (no) 1987-01-29

Similar Documents

Publication Publication Date Title
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
LV5760B4 (lv) Jauns farmaceitisks preparats peroralai lietosanai
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT1213379B (it) Tiazolo [4,5-c]chinoline, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
IL81950A0 (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof processes for the preparation thereof and pharmaceutical compositions containing them
IT8767057A0 (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
IL81934A (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and salts thereof,processes for their preparation and pharmaceutical compositions containing them
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
AR242206A1 (es) Procedimiento para la preparacion de derivados de acido 3-desmetil-mevalonico, preparados farmaceuticos en base a los mismos,y productos intermediarios para uso exclusivo.
IL81949A0 (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof,processes for their preparation and pharmaceutical compositions containing them
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
IT1205817B (it) Benzammidi sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8519065A1 (it) Composti con attivita' antitossica fd antianemica, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8619751A0 (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione.
IT1218324B (it) Composti ad attivita' calcio-antagonista,metodo per la loro preparazione e composizioni farmaceutiche
IT1217192B (it) Tioeteri chinolinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1222140B (it) Composti ad attivita' antivirale,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8422042A0 (it) Composti antibatterici, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8622881A0 (it) 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
IT8422445A0 (it) Composti antiinfiammatori ed analgesici, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8619624A0 (it) Piperazine asimmetriche adattivita' farmacologica, procedimento per la loro preparazione e composizione farmaceutiche relative.
IT8723170A0 (it) Composizioni farmaceutiche a base di nedocromil sodio, metodi per la loro preparazione, e loro uso
IT8947985A0 (it) Nuovi sali di glicosaminoglicani, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8719564A0 (it) Piperazine asimmetriche adattivita' farmacologica, procedimento per la loro preparazione e compisizioni farmaceutiche relative.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990129